REFRACTORY OSTEOSARCOMA

Clinical trials for REFRACTORY OSTEOSARCOMA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY OSTEOSARCOMA trials appear

Sign up with your email to follow new studies for REFRACTORY OSTEOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 6 Not yet recruiting 1 Not yet finished but already full! 12 Completed 2

Double immune attack: new cell combo targets tough childhood cancers

Disease control Not yet recruiting

This early-phase study tests a new combination of two types of immune cells—NK cells and CAR-T cells—for people whose neuroblastoma or osteosarcoma has returned or not responded to standard treatments. The cells are modified to better recognize and fight cancer and to survive lon…

Matched conditions: REFRACTORY OSTEOSARCOMA

Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control

Last updated May 07, 2026 18:40 UTC

REFRACTORY OSTEOSARCOMA

Get alerted when new REFRACTORY OSTEOSARCOMA trials appear

Double immune attack: new cell combo targets tough childhood cancers